Literature DB >> 15188312

Could the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) be a valid measure of disease activity in patients with psoriatic arthritis?

William J Taylor1, Andrew A Harrison.   

Abstract

OBJECTIVE: To determine whether the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) could be a valid indicator of disease activity in psoriatic arthritis (PsA).
METHODS: Patients with PsA identified from a disease-register and case-note review answered a questionnaire by mail (n = 133); some patients (n = 86) consented to examination. In a second sample of 47 consecutive clinic attendees with PsA, logistic regression examined the independent contribution of BASDAI to disease activity, as judged by treatment decisions at that time.
RESULTS: BASDAI correlated highly with patient perception of disease activity (r = 0.739) and there was no significant effect of the pattern of disease (axial or peripheral) on this relationship. However, only physician perception of disease activity was significantly associated with high or low disease activity (odds ratio 18.4, 95% confidence interval 2.9-118.3). BASDAI, patient perception, and erythrocyte sedimentation rate failed to contribute significantly to the model.
CONCLUSION: BASDAI performs similarly for axial and peripheral PsA but does not correlate well with external indicators of disease activity, such as treatment decisions.

Entities:  

Mesh:

Year:  2004        PMID: 15188312     DOI: 10.1002/art.20421

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  23 in total

1.  Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.

Authors:  Erkan Kilic; Gamze Kilic; Ozgur Akgul; Salih Ozgocmen
Journal:  Rheumatol Int       Date:  2014-11-04       Impact factor: 2.631

Review 2.  Seronegative spondyloarthropathies: to lump or split?

Authors:  P Nash; P J Mease; J Braun; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2005-03       Impact factor: 19.103

3.  Comparison of ASDAS and BASDAI as a measure of disease activity in axial psoriatic arthritis.

Authors:  Gamze Kılıç; Erkan Kılıç; Kemal Nas; Murat Karkucak; Erhan Çapkın; Abdullah Zübeyir Dağlı; Remzi Çevik; Salih Özgöçmen
Journal:  Clin Rheumatol       Date:  2014-07-02       Impact factor: 2.980

Review 4.  Psoriatic arthritis: phenotypic variance and nosology.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2013-03       Impact factor: 4.592

Review 5.  Patient-Reported Outcomes in Psoriatic Arthritis.

Authors:  Ana-Maria Orbai; Alexis Ogdie
Journal:  Rheum Dis Clin North Am       Date:  2016-03-16       Impact factor: 2.670

Review 6.  Outcome measures in psoriatic arthritis clinical trials.

Authors:  Soumya M Reddy; Clifton O Bingham III
Journal:  Curr Rheumatol Rep       Date:  2005-08       Impact factor: 4.592

Review 7.  Axial psoriatic arthritis: an intriguing clinical entity or a subset of an intriguing disease?

Authors:  Ennio Lubrano; Antonio Spadaro
Journal:  Clin Rheumatol       Date:  2012-05-03       Impact factor: 2.980

8.  The Bath Ankylosing Spondylitis Activity and Function Indices (BASDAI and BASFI) and their correlation with main symptoms experienced by patients with spondyloarthritis.

Authors:  Euthalia Roussou; Shahzabeen Sultana
Journal:  Clin Rheumatol       Date:  2010-03-14       Impact factor: 2.980

9.  Phenotypic and clinical differences between Caucasian and South Asian patients with psoriatic arthritis living in North East London.

Authors:  Euthalia Roussou; Sunil Chopra; Danny Lunda Ngandu
Journal:  Clin Rheumatol       Date:  2012-12-18       Impact factor: 2.980

Review 10.  Axial disease in psoriatic arthritis.

Authors:  Dafna D Gladman
Journal:  Curr Rheumatol Rep       Date:  2007-12       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.